Our Services
Medical Information
Helpful Resources
Published on: 5/6/2026
Trazodone can lengthen the heart’s QT interval, leading to palpitations and, in rare cases, dangerous arrhythmias. Doctors monitor your rhythm using ECGs and wearable devices so they can detect abnormalities early and adjust your dose or treatment.
There are multiple risk factors including heart disease, electrolyte imbalances and interacting medications, so see below for the complete information and next steps you should discuss with your provider.
Trazodone is a commonly prescribed medication for depression, anxiety, and insomnia. While it's generally well tolerated, certain heart-related side effects—such as heart palpitations—can occur. That's why your doctor often monitors your heart rhythm when you start or adjust your dose of trazodone. Below, we explain the reasons behind this practice and what you can expect.
Trazodone belongs to the class of medications called serotonin modulators. It works by increasing levels of serotonin in the brain, which can improve mood and help with sleep. Unlike many other antidepressants, trazodone has sedating properties at lower doses, making it a dual-purpose drug.
QT Interval Prolongation
Trazodone can lengthen the QT interval—a measure on an electrocardiogram (ECG/EKG) that reflects how quickly your heart recharges between beats. A prolonged QT interval can increase the risk of a rare but potentially life-threatening arrhythmia called torsades de pointes.
Arrhythmia Prevention
Monitoring helps catch abnormal heart rhythms early. If an arrhythmia is detected, your doctor can adjust the dose, switch medications, or recommend further testing.
Dose Adjustments
Higher doses of trazodone carry a greater risk of cardiac effects. Regular checks allow your prescriber to find the lowest effective dose with the best safety profile.
Co-existing Conditions
Patients with existing heart disease, electrolyte imbalances, or those taking other QT-prolonging drugs are at higher risk. Monitoring tailors care to each individual's health status.
Not everyone on trazodone requires intensive monitoring. Your doctor will consider:
If you fall into any of these categories, your healthcare provider may order:
It's helpful to know what palpitations feel like and when to reach out to your doctor:
Most palpitations are benign, but if you notice new, persistent, or worsening symptoms, discuss them with your healthcare provider.
You can take steps to keep your heart safe while benefiting from trazodone:
If you experience any of the following, seek medical advice promptly:
If you're unsure whether your symptoms require immediate attention, you can get personalized guidance by using a Medically approved LLM Symptom Checker Chat Bot to help determine your next steps and whether urgent care is needed.
It's important to remember:
By working closely with your healthcare team, you can maximize the benefits of trazodone while minimizing potential cardiac risks.
Monitoring your heart rhythm while on trazodone isn't meant to alarm you—it's a standard safety measure. It helps ensure that you receive the optimal dose for your needs without compromising your cardiac health. Always be honest about any new symptoms, no matter how minor they seem.
If you notice concerning heart palpitations or other serious signs, speak to a doctor immediately. Never ignore symptoms that could be life-threatening. For questions about new or changing symptoms between appointments, try consulting a Medically approved LLM Symptom Checker Chat Bot for instant, AI-powered guidance on what to do next.
Your health is a team effort—stay informed, stay proactive, and stay in touch with your medical provider.
(References)
* Li H, Wang T, Fang J, et al. Trazodone-induced QTc prolongation: A systematic review and meta-analysis. J Clin Psychopharmacol. 2023 Jan-Feb 01;43(1):31-38. doi: 10.1097/JCP.0000000000001633. PMID: 36692994.
* Zhang Y, Liu Q, Zhang X, et al. Cardiac safety of trazodone: a systematic review and meta-analysis. Expert Opin Drug Saf. 2021 Aug;20(8):1021-1033. doi: 10.1080/14740338.2021.1947849. Epub 2021 Jun 30. PMID: 34180424.
* Al-Jaghbir MJ, Yaser SA, Al-Jaghbir MM. Trazodone and QTc prolongation: A comprehensive review of the literature. Curr Drug Saf. 2022;17(4):307-313. doi: 10.2174/1574886317666220627103855. PMID: 35767188.
* Fagiolini A, Comandini A, Dell'Osso L, et al. Trazodone and cardiac risk: A review. J Clin Psychopharmacol. 2018 Jan/Feb;38(1):52-59. doi: 10.1097/JCP.0000000000000788. PMID: 29300305.
* Kim N, Cha SH, Ahn SM, et al. Trazodone-Induced Torsade de Pointes in an Elderly Patient with Multiple Risk Factors: A Case Report and Literature Review. Clin Psychopharmacol Neurosci. 2020 Aug 31;18(3):477-481. doi: 10.9758/cpn.2020.18.3.477. PMID: 32660447.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.